Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01376310
Title GSK1120212 Rollover Study
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | FRA | CAN

Facility Status City State Zip Country Details
Novartis Investigative Site Goodyear Arizona 85338 United States Details
Novartis Investigative Site Scottsdale Arizona 85259 United States Details
Novartis Investigative Site Sacramento California 95817 United States Details
Novartis Investigative Site Aurora Colorado 80045 United States Details
Novartis Investigative Site New Haven Connecticut 06510 United States Details
Novartis Investigative Site Sarasota Florida 34232 United States Details
Novartis Investigative Site New York New York 10016 United States Details
Novartis Investigative Site Philadelphia Pennsylvania 19104 United States Details
Novartis Investigative Site Nashville Tennessee 37203 United States Details
Novartis Investigative Site Houston Texas 77030 United States Details
Novartis Investigative Site San Antonio Texas 78229 United States Details
Novartis Investigative Site Salt Lake City Utah 84112 United States Details
Novartis Investigative Site Tacoma Washington 98405 United States Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Toulouse Cedex 9 31059 France Details
Novartis Investigative Site Villejuif Cedex 94805 France Details
Novartis Investigative Site Seoul 135-710 Korea, Republic of Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field